HomeCompareBRRGF vs VICI

BRRGF vs VICI: Dividend Comparison 2026

BRRGF yields 2.06% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $943.5K in total portfolio value
10 years
BRRGF
BRRGF
● Live price
2.06%
Share price
$97.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.7K
Annual income
$235.33
Full BRRGF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — BRRGF vs VICI

📍 VICI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBRRGFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BRRGF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BRRGF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRRGF
Annual income on $10K today (after 15% tax)
$175.09/yr
After 10yr DRIP, annual income (after tax)
$200.03/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $516,069.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRRGF + VICI for your $10,000?

BRRGF: 50%VICI: 50%
100% VICI50/50100% BRRGF
Portfolio after 10yr
$494.5K
Annual income
$303,805.73/yr
Blended yield
61.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

BRRGF
No analyst data
Altman Z
2821.3
Piotroski
2/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRRGF buys
0
VICI buys
11
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002024-10-14
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002024-03-25
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002024-03-20
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002024-02-13
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002023-11-03
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-10-10
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002023-09-06
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-08-29
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-07-28
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-06-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBRRGFVICI
Forward yield2.06%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$22.7K$966.2K
Annual income after 10y$235.33$607,376.13
Total dividends collected$2.2K$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BRRGF vs VICI ($10,000, DRIP)

YearBRRGF PortfolioBRRGF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$10,906$205.99$11,361$941.49$455.00VICI
2$11,879$209.95$13,320$1,481.32$1.4KVICI
3$12,925$213.73$16,284$2,405.01$3.4KVICI
4$14,047$217.32$21,040$4,071.78$7.0KVICI
5$15,251$220.74$29,209$7,285.49$14.0KVICI
6$16,542$223.98$44,443$14,006.51$27.9KVICI
7$17,927$227.05$75,822$29,512.55$57.9KVICI
8$19,412$229.97$148,733$69,726.75$129.3KVICI
9$21,004$232.72$344,394$189,413.75$323.4KVICI
10$22,709$235.33$966,234$607,376.13$943.5KVICI

BRRGF vs VICI: Complete Analysis 2026

BRRGFStock

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, a bio-available small molecule AXL inhibitor, which is in Phase II clinical development in major cancer indications and COVID-19. Its Phase II clinical trial program focuses on treatment of non-small cell lung cancer, acute myeloid leukaemia, and myelodysplastic syndrome, as well as COVID-19. In addition, it is developing tilvestamab, an anti-AXL antibody that is in Phase Ib clinical trial. BerGenBio ASA has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Full BRRGF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this BRRGF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRRGF vs SCHDBRRGF vs JEPIBRRGF vs OBRRGF vs KOBRRGF vs MAINBRRGF vs NNNBRRGF vs EPRTBRRGF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.